Obesity and Metabolic Disorders

The metabolic syndrome is a condition considered by a special constellation of revocable major risk factors for cardiac disease and type 2 diabetes. The main, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference.

Obesity is becoming a worldwide epidemic. The epidemic of obesity has been paralleled by an increase in the incidence of chronic kidney disease (CKD). Several recent epidemiologic studies have shown that obesity and the metabolic syndrome are independent predictors of CKD. The prevalence of marked obesity is increasing rapidly among adults and has more than doubled in 10 years. 61% of the adult population of the United States is overweight or obese. 

 

  • Chronic Kidney Disease
  • Cardiovascular Therapy

Related Conference of Obesity and Metabolic Disorders

May 08-09, 2025

5th European Endocrinology and Diabetes Congress

Madrid, Spain
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Obesity and Metabolic Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in